June 2025
1. ZIAI WC, Tsivgoulis G
   Timing of anticoagulation after ischaemic stroke and atrial fibrillation: better swift than sorry.
   Lancet. 2025 Jun 23:S0140-6736(25)00676-2. doi: 10.1016/S0140-6736(25)00676.
   

   >> Share

   
   
2. DEHBI HM, Fischer U, Asberg S, Milling TJ, et al
   Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST).
   Lancet. 2025 Jun 23:S0140-6736(25)00439-8. doi: 10.1016/S0140-6736(25)00439.
   

   >> Share

   
   February 2025
3. SALMAN RA, Shoamanesh A
   Towards definitive evidence about anticoagulation for atrial fibrillation after intracranial haemorrhage.
   Lancet. 2025 Feb 26:S0140-6736(25)00366-6. doi: 10.1016/S0140-6736(25)00366.
   

   >> Share

   
   
4. VELTKAMP R, Korompoki E, Harvey KH, Harvey ER, et al
   Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial.
   Lancet. 2025 Feb 26:S0140-6736(25)00333-2. doi: 10.1016/S0140-6736(25)00333.
   

   >> Share

   
   October 2024
5. WERRING DJ, Dehbi HM, Ahmed N, Arram L, et al
   Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.
   Lancet. 2024 Oct 23:S0140-6736(24)02197-4. doi: 10.1016/S0140-6736(24)02197.
   

   >> Share

   
   
6. SANDSET EC, de Sousa DA
   Optimal anticoagulation timing after ischaemic stroke in patients with atrial fibrillation.
   Lancet. 2024 Oct 23:S0140-6736(24)02259-1. doi: 10.1016/S0140-6736(24)02259.
   

   >> Share

   
   September 2024
7. PREVEL R, Boyer A, Gruson D, Orieux A, et al
   Catheter ablation for atrial fibrillation, atrio-oesophageal fistula, cerebral air embolism, and hyperbaric oxygen therapy.
   Lancet. 2024;404:1051-1052.
   

   >> Share

   
   November 2023
8. HEERSPINK HJL, Kiyosue A, Wheeler DC, Lin M, et al
   Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial.
   Lancet. 2023 Nov 2:S0140-6736(23)02230-4. doi: 10.1016/S0140-6736(23)02230.
   

   >> Share

   
   September 2023
9. FUJIMOTO Y, Iwasaki YK, Asai K
   Pericardial-oesophageal fistula after ablation for atrial fibrillation.
   Lancet. 2023;402:882.
   

   >> Share

   
   August 2023
10. WILKOFF BL, Filippatos G, Leclercq C, Gold MR, et al
    Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial.
    Lancet. 2023 Aug 24:S0140-6736(23)00912-1. doi: 10.1016/S0140-6736(23)00912.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share